WebHeader_Grove.png
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Get 2 limited-edition podcast mugs when you make a sustaining gift of $8 or more per month today!

Firm Uses Artificial Intelligence In Drug Development

A researcher at Berg Health's laboratory in Framingham. (Courtesy of Berg Health)
A researcher at Berg Health's laboratory in Framingham. (Courtesy of Berg Health)

It’s called BPM 31510 and it is one of many cancer drugs being developed around the country. But it’s also different.

BPM 31510 may be the first drug candidate that was developed by artificial intelligence, instead of scientists running experiments based on a hypothesis.

From the Here & Now Contributors Network, WBUR’s Curt Nickisch reports.

Reporter

Copyright 2021 NPR. To see more, visit https://www.npr.org.

You make NHPR possible.

NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.